Research study Program year 2021 Source: CMS Open Payments

A 28-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Grou

Research payments

$2,480,675

559 payments

Through program year 2021, $2,480,675 in research payments was reported against A 28-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Grou, across 559 payments, paid by GlaxoSmithKline, LLC..

Paid by: GlaxoSmithKline, LLC.
ClinicalTrials.gov: No trial number was reported for this study

By program year

3 rows

Year	Kind	Amount	Payments
2021	Research	$302,961	109
2020	Research	$1,084,347	215
2019	Research	$1,093,367	235

Breakdown

Who paid Research payments · program years 2019–2021

GlaxoSmithKline, LLC. $2,480,675 559 payments

Who received the money Research payments · program years 2019–2021

Amicis Research Center Organisation paid for research $316,072 17 payments
South Florida Research Institute Organisation paid for research $186,618 25 payments
South Carolina Nephrology And Hyper Organisation paid for research $162,146 16 payments
Chris Sholer MD Pc Organisation paid for research $117,959 15 payments
Atekha Nephrology Clinic Organisation paid for research $117,611 16 payments
Denver Nephrologists Organisation paid for research $114,191 12 payments
Central Coast Nephrology Organisation paid for research $96,198 8 payments
West Broward Research Institution Organisation paid for research $94,788 21 payments
Polack Renal Organisation paid for research $81,288 27 payments
Durham Nephrology Organisation paid for research $70,831 25 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.